Add Yahoo as a preferred source to see more of our stories on Google. A vial of the Pfizer/BioNTech Comirnaty vaccine against Covid-19 at a mass vaccination center on July 1, 2021 in Leipzig, Germany.

Add Yahoo as a preferred source to see more of our stories on Google. In this photo illustration, Pfizer-BioNTech COVID-19 and Moderna COVID-19 vaccines fill their syringes at Borinquen Health Care ...

The U.S. Food and Drug Administration on Wednesday amended the emergency use authorizations of the Moderna and Pfizer-BioNTech COVID-19 vaccines to authorize updated boosters to combat omicron ...

By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the ...

A guide to coronavirus vaccination rollout and what you need to know about the authorized vaccines. Some 63.8% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna drugs ...

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants 1 – compared to ...

Pfizer and BioNTech have paused a large U.S. clinical trial designed to test their updated COVID-19 vaccine in healthy adults ...

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but still up in the air is how much benefit the booster shots will offer, who should get one — ...